CJC-1295: Difference between revisions

Latest revision as of 03:42, 13 February 2025

Overview[edit]

CJC-1295 is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is primarily used in research settings to study its effects on growth hormone (GH) secretion and its potential therapeutic applications.

Mechanism of Action[edit]

CJC-1295 works by binding to the growth hormone-releasing hormone receptor (GHRHR) on the surface of pituitary gland cells. This binding stimulates the release of growth hormone from the pituitary gland into the bloodstream. The increased levels of growth hormone can lead to various physiological effects, including increased muscle mass, reduced body fat, and improved recovery from injuries.

Structure and Composition[edit]

CJC-1295 is a modified form of the natural GHRH. It has been engineered to have a longer half-life than endogenous GHRH, allowing for less frequent dosing. The addition of a Drug Affinity Complex (DAC) extends its half-life by allowing it to bind to albumin in the bloodstream, thereby protecting it from rapid degradation.

Clinical Applications[edit]

While CJC-1295 is not approved for clinical use, it is of interest in the field of endocrinology for its potential to treat conditions associated with growth hormone deficiency. Research is ongoing to determine its efficacy and safety in various populations, including those with HIV/AIDS-related wasting and age-related muscle loss.

Side Effects[edit]

Potential side effects of CJC-1295 include injection site reactions, such as redness and swelling, as well as systemic effects like headache, nausea, and dizziness. Long-term effects are not well-documented due to the lack of extensive clinical trials.

Related Compounds[edit]

CJC-1295 is often compared to other GHRH analogs and growth hormone secretagogues such as Sermorelin and Ipamorelin. These compounds also aim to increase growth hormone levels but differ in their structure, half-life, and receptor affinity.

Research and Development[edit]

Research on CJC-1295 is ongoing, with studies focusing on its pharmacokinetics, optimal dosing regimens, and potential therapeutic applications. Animal studies have shown promising results, but more human trials are needed to fully understand its benefits and risks.

Related Pages[edit]

@@ Line 1: / Line 1: @@
-'''CJC-1295''' is a synthetic peptide hormone, which is widely recognized in the field of medicine for its ability to stimulate the release of [[Growth Hormone]] (GH). It belongs to a class of growth hormone-releasing hormones (GHRH) analogs and has gained popularity in both clinical settings and among bodybuilders for its potential benefits, including increased muscle mass, improved injury recovery, and enhanced overall well-being.
+{{DISPLAYTITLE:CJC-1295}}
-==Overview==
+== Overview ==
-CJC-1295 was developed by ConjuChem, a biotechnology company, with the aim of increasing the half-life of GHRH to enhance its therapeutic potential. Unlike natural GHRH, which has a short half-life in circulation, CJC-1295 is modified by the addition of [[Drug Affinity Complex]] (DAC), which significantly extends its duration of action. This modification allows for less frequent dosing schedules in therapeutic applications, making it a more convenient option for patients requiring growth hormone therapy.
+[[File:CJC-1295_DAC.svg|thumb|right|Chemical structure of CJC-1295 with DAC]]
+'''CJC-1295''' is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is primarily used in research settings to study its effects on growth hormone (GH) secretion and its potential therapeutic applications.
-==Mechanism of Action==
+== Mechanism of Action ==
-The primary mechanism of action of CJC-1295 involves binding to the [[Growth Hormone-Releasing Hormone Receptor]] (GHRHR) on the surface of the pituitary gland. This interaction stimulates the pituitary gland to release growth hormone into the bloodstream. The presence of DAC in CJC-1295 increases its half-life by protecting it from rapid degradation, thereby prolonging its stimulatory effect on GH release.
+CJC-1295 works by binding to the [[growth hormone-releasing hormone receptor]] (GHRHR) on the surface of [[pituitary gland]] cells. This binding stimulates the release of [[growth hormone]] from the pituitary gland into the bloodstream. The increased levels of growth hormone can lead to various physiological effects, including increased muscle mass, reduced body fat, and improved recovery from injuries.
-==Clinical Applications==
+== Structure and Composition ==
-CJC-1295 has been explored for various clinical applications, primarily focusing on conditions that benefit from enhanced growth hormone levels. These include but are not limited to:
+CJC-1295 is a modified form of the natural GHRH. It has been engineered to have a longer half-life than endogenous GHRH, allowing for less frequent dosing. The addition of a Drug Affinity Complex (DAC) extends its half-life by allowing it to bind to [[albumin]] in the bloodstream, thereby protecting it from rapid degradation.
-* [[Growth Hormone Deficiency]] in both children and adults
+== Clinical Applications ==
-* Muscle wasting diseases
+While CJC-1295 is not approved for clinical use, it is of interest in the field of [[endocrinology]] for its potential to treat conditions associated with growth hormone deficiency. Research is ongoing to determine its efficacy and safety in various populations, including those with [[HIV/AIDS]]-related wasting and age-related muscle loss.
-* Obesity
-* Aging and related conditions
-Despite its potential, the clinical use of CJC-1295 is still under investigation, and it has not been approved by regulatory bodies such as the [[Food and Drug Administration]] (FDA) for any medical condition.
+== Side Effects ==
+Potential side effects of CJC-1295 include injection site reactions, such as redness and swelling, as well as systemic effects like headache, nausea, and dizziness. Long-term effects are not well-documented due to the lack of extensive clinical trials.
-==Bodybuilding and Athletic Performance==
+== Related Compounds ==
-In the realm of bodybuilding and sports, CJC-1295 has been used off-label for its anabolic effects. Athletes and bodybuilders claim that it helps in building muscle mass, reducing body fat, and improving recovery times after injuries or intense training sessions. However, it is important to note that the use of CJC-1295 for athletic enhancement is not supported by clinical evidence and is prohibited by sports regulatory bodies like the [[World Anti-Doping Agency]] (WADA).
+CJC-1295 is often compared to other GHRH analogs and [[growth hormone secretagogues]] such as [[Sermorelin]] and [[Ipamorelin]]. These compounds also aim to increase growth hormone levels but differ in their structure, half-life, and receptor affinity.
-==Safety and Side Effects==
+== Research and Development ==
-The safety profile of CJC-1295 is still being studied, but common side effects reported include injection site reactions, headache, flushing, and dizziness. Long-term use and higher doses may increase the risk of more serious side effects, such as increased risk of diabetes, joint pain, and carpal tunnel syndrome due to elevated growth hormone levels.
+Research on CJC-1295 is ongoing, with studies focusing on its pharmacokinetics, optimal dosing regimens, and potential therapeutic applications. Animal studies have shown promising results, but more human trials are needed to fully understand its benefits and risks.
-==Legal Status==
+== Related Pages ==
-CJC-1295 is classified as a research chemical and is not approved for use outside of clinical trials in many countries. Its availability on the black market and use in bodybuilding communities have raised concerns about its safety and efficacy without proper medical supervision.
+* [[Growth hormone-releasing hormone]]
+* [[Growth hormone]]
-==Conclusion==
+* [[Pituitary gland]]
-CJC-1295 represents a significant advancement in the field of growth hormone-releasing hormone analogs due to its prolonged half-life and potential therapeutic benefits. However, its use remains limited to clinical studies and investigational applications until more definitive safety and efficacy data are available. Individuals considering CJC-1295 for bodybuilding or other non-medical uses should be aware of the risks and legal implications.
+* [[Endocrinology]]
 [[Category:Peptides]]
-[[Category:Hormones]]
+[[Category:Growth hormone secretagogues]]
-[[Category:Endocrinology]]
-[[Category:Drug Discovery]]
-{{medicine-stub}}
-{{No image}}